APVO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aptevo Therapeutics Inc (APVO).


$2.16M Market Cap.

As of 02/14/2025 5:00 PM ET (MRY) • Disclaimer

APVO Market Cap. (MRY)


APVO Shares Outstanding (MRY)


APVO Assets (MRY)


Total Assets

$15.59M

Total Liabilities

$10.84M

Total Investments

$0

APVO Income (MRY)


Revenue

$0

Net Income

-$24.13M

Operating Expense

$24.60M

APVO Cash Flow (MRY)


CF Operations

-$23.79M

CF Investing

$0

CF Financing

$15.60M

APVO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

APVO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$15,591,000 (-37.24%)

$24,842,000 (-27.39%)

$34,215,000 (-39.55%)

$56,601,000 (5.70%)

Assets Current

$10,659,000 (-44.09%)

$19,066,000 (-30.54%)

$27,450,000 (-47.78%)

$52,570,000 (11.23%)

Assets Non-Current

$4,932,000 (-14.61%)

$5,776,000 (-14.62%)

$6,765,000 (67.82%)

$4,031,000 (-35.84%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$4,755,000 (-61.09%)

$12,221,000 (-32.01%)

$17,974,000 (1378.13%)

$1,216,000 (-92.67%)

Property Plant & Equipment Net

$4,932,000 (-14.61%)

$5,776,000 (-14.62%)

$6,765,000 (70.70%)

$3,963,000 (-28.43%)

Cash & Equivalents

$8,714,000 (-48.45%)

$16,904,000 (-25.32%)

$22,635,000 (-51.12%)

$46,303,000 (8.86%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$2,500,000 (-31.77%)

$3,664,000 (54.66%)

Trade & Non-Trade Payables

$3,053,000 (-23.37%)

$3,984,000 (13.86%)

$3,499,000 (1.07%)

$3,462,000 (-37.99%)

Accumulated Retained Earnings (Deficit)

-$247,577,000 (-10.80%)

-$223,447,000 (-8.45%)

-$206,036,000 (3.75%)

-$214,063,000 (-15.33%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$4,629,000 (-14.23%)

$5,397,000 (-43.40%)

$9,535,000 (-42.96%)

$16,715,000 (-39.03%)

Debt Current

$0 (0%)

$0 (0%)

$2,000,000 (-82.86%)

$11,667,000 (133.34%)

Debt Non-Current

$4,629,000 (-14.23%)

$5,397,000 (-28.37%)

$7,535,000 (49.27%)

$5,048,000 (-77.48%)

Total Liabilities

$10,836,000 (-14.14%)

$12,621,000 (-22.29%)

$16,241,000 (-70.68%)

$55,385,000 (49.88%)

Liabilities Current

$6,207,000 (-14.08%)

$7,224,000 (-17.02%)

$8,706,000 (-74.95%)

$34,757,000 (139.06%)

Liabilities Non-Current

$4,629,000 (-14.23%)

$5,397,000 (-28.37%)

$7,535,000 (-63.47%)

$20,628,000 (-7.97%)

APVO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$3,114,000 (-74.67%)

$12,292,000 (185.26%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$10,224,000 (-13.14%)

$11,771,000 (-15.15%)

$13,873,000 (-5.61%)

$14,698,000 (5.35%)

Research & Development Expense

$14,378,000 (-15.95%)

$17,107,000 (-4.33%)

$17,882,000 (-5.85%)

$18,994,000 (6.40%)

Operating Expenses

$24,602,000 (-14.81%)

$28,878,000 (-9.06%)

$31,755,000 (-5.75%)

$33,692,000 (1.70%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

-$1,239,000 (-22.31%)

-$1,013,000 (-6.52%)

-$951,000 (92.78%)

Consolidated Income

-$24,130,000 (-38.59%)

-$17,411,000 (-316.91%)

$8,027,000 (128.21%)

-$28,457,000 (-60.32%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$24,130,000 (-38.59%)

-$17,411,000 (-316.91%)

$8,027,000 (128.21%)

-$28,457,000 (-60.32%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$24,130,000 (-38.59%)

-$17,411,000 (-316.91%)

$8,027,000 (128.21%)

-$28,457,000 (-60.32%)

Weighted Average Shares

$276,137 (-0.69%)

$278,060 (-94.55%)

$5,100,310 (8.80%)

$4,687,952 (38.25%)

Weighted Average Shares Diluted

$276,137 (-0.69%)

$278,060 (-94.55%)

$5,102,914 (8.85%)

$4,687,952 (38.25%)

Earning Before Interest & Taxes (EBIT)

-$24,130,000 (-38.59%)

-$17,411,000 (-316.91%)

$8,027,000 (128.21%)

-$28,457,000 (-60.32%)

Gross Profit

$0 (0%)

$0 (0%)

$3,114,000 (-74.67%)

$12,292,000 (185.26%)

Operating Income

-$24,602,000 (14.81%)

-$28,878,000 (-0.83%)

-$28,641,000 (-33.84%)

-$21,400,000 (25.74%)

APVO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

-$29,000 (95.93%)

-$713,000 (-102.54%)

Net Cash Flow from Financing

$15,595,000 (160.00%)

$5,998,000 (329.28%)

-$2,616,000 (-110.00%)

$26,161,000 (9.58%)

Net Cash Flow from Operations

-$23,785,000 (-102.77%)

-$11,730,000 (44.20%)

-$21,022,000 (3.03%)

-$21,679,000 (26.06%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$8,190,000 (-42.88%)

-$5,732,000 (75.78%)

-$23,667,000 (-727.94%)

$3,769,000 (-83.31%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

-$29,000 (95.93%)

-$713,000 (-710.23%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$3,467,000 (71.74%)

-$12,267,000 (-16.27%)

-$10,550,000 (-501.60%)

Issuance (Purchase) of Equity Shares

$15,596,000 (64.60%)

$9,475,000 (36.65%)

$6,934,000 (-39.38%)

$11,438,000 (-46.19%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,069,000 (-51.25%)

$2,193,000 (21.70%)

$1,802,000 (9.68%)

$1,643,000 (30.92%)

Depreciation Amortization & Accretion

$352,000 (-37.92%)

$567,000 (-37.07%)

$901,000 (-21.24%)

$1,144,000 (-18.63%)

APVO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-

257.80% (211.36%)

-231.50% (43.80%)

EBITDA Margin

-

-

286.70% (229.03%)

-222.20% (41.42%)

Return on Average Equity (ROAE)

-488.90% (-366.51%)

-104.80% (-266.09%)

63.10% (118.23%)

-346.10% (-107.62%)

Return on Average Assets (ROAA)

-152.50% (-153.74%)

-60.10% (-380.84%)

21.40% (149.08%)

-43.60% (17.27%)

Return on Sales (ROS)

-

-

257.80% (211.36%)

-231.50% (43.80%)

Return on Invested Capital (ROIC)

-395.60% (-66.85%)

-237.10% (-302.30%)

117.20% (-80.06%)

587.90% (643.85%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.05 (61.42%)

-0.13 (-108.59%)

1.48 (213.96%)

-1.3 (81.49%)

Price to Sales Ratio (P/S)

-

-

3.8 (26.62%)

3 (-89.59%)

Price to Book Ratio (P/B)

0.45 (73.95%)

0.26 (-60.27%)

0.66 (-97.93%)

31.7 (246.26%)

Debt to Equity Ratio (D/E)

2.28 (120.62%)

1.03 (14.27%)

0.9 (-98.02%)

45.55 (1945.22%)

Earnings Per Share (EPS)

-87.38 (-39.85%)

-62.48 (-4079.62%)

1.57 (125.86%)

-6.07 (-16.06%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0.61 (-76.70%)

2.62 (106.29%)

Free Cash Flow Per Share (FCFPS)

-86.14 (-104.18%)

-42.19 (-922.17%)

-4.13 (13.59%)

-4.78 (44.93%)

Book Value Per Share (BVPS)

17.22 (-60.82%)

43.95 (1147.19%)

3.52 (1260.62%)

0.26 (-94.71%)

Tangible Assets Book Value Per Share (TABVPS)

56.46 (-36.80%)

89.34 (1231.84%)

6.71 (-44.44%)

12.07 (-23.54%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

1 (0%)

0 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.03 (-94.79%)

0.61 (989.86%)

-0.07 (4.17%)

-0.07 (99.23%)

Asset Turnover

0 (0%)

0 (0%)

0.08 (-56.08%)

0.19 (47.66%)

Current Ratio

1.72 (-34.94%)

2.64 (-16.30%)

3.15 (108.39%)

1.51 (-53.46%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$23,785,000 (-102.77%)

-$11,730,000 (44.28%)

-$21,051,000 (5.99%)

-$22,392,000 (23.85%)

Enterprise Value (EV)

-$766,592 (92.59%)

-$10,346,364 (-1576.55%)

-$617,121 (-131.49%)

$1,959,528 (-98.71%)

Earnings Before Tax (EBT)

-$24,130,000 (-38.59%)

-$17,411,000 (-316.91%)

$8,027,000 (128.21%)

-$28,457,000 (-60.32%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$23,778,000 (-41.17%)

-$16,844,000 (-288.66%)

$8,928,000 (132.69%)

-$27,313,000 (-67.11%)

Invested Capital

$5,299,000 (-13.29%)

$6,111,000 (-50.75%)

$12,409,000 (260.24%)

-$7,744,000 (-132.42%)

Working Capital

$4,452,000 (-62.40%)

$11,842,000 (-36.82%)

$18,744,000 (5.23%)

$17,813,000 (-45.57%)

Tangible Asset Value

$15,591,000 (-37.24%)

$24,842,000 (-27.39%)

$34,215,000 (-39.55%)

$56,601,000 (5.70%)

Market Capitalization

$2,156,408 (-32.37%)

$3,188,636 (-73.01%)

$11,812,879 (-69.36%)

$38,547,528 (-74.63%)

Average Equity

$4,935,250 (-70.29%)

$16,612,000 (30.55%)

$12,724,750 (54.74%)

$8,223,250 (-22.78%)

Average Assets

$15,821,750 (-45.37%)

$28,963,000 (-22.71%)

$37,473,250 (-42.53%)

$65,208,250 (93.61%)

Invested Capital Average

$6,099,000 (-16.94%)

$7,343,000 (7.19%)

$6,850,500 (241.52%)

-$4,840,750 (-129.49%)

Shares

500,327 (24.96%)

400,381 (-92.14%)

5,091,758 (3.96%)

4,898,034 (18.17%)